Matanandao, Rosemae S.
HRN: 23-12-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CEFUROXIME 1.5GM (VIAL)
05/31/2023
06/07/2023
IV
1.5gms
Q8hrs
G1P0(0010) Abortion; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes